ScottishNews.com

Events
News Features Food and Drink Best of Scotland Music What's On Watch
Events

Life Sciences


More stories

1 June 2023

Finance

Pneumagen raises £8m to accelerate drug development

St Andrews-based biotech firm Pneumagen has secured £8 million in financing from existing and new investors to support the continued Phase 2 development of Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs).